Hemidystonia improved by intrathecal baclofen infusion therapy: A case report

IF 0.4 Q4 CLINICAL NEUROLOGY
Takashi Asahi , Kiyonobu Ikeda , Shiro Horisawa , Taku Nonaka , Yuko Muro , Nobutaka Yamamoto , Takaomi Taira
{"title":"Hemidystonia improved by intrathecal baclofen infusion therapy: A case report","authors":"Takashi Asahi ,&nbsp;Kiyonobu Ikeda ,&nbsp;Shiro Horisawa ,&nbsp;Taku Nonaka ,&nbsp;Yuko Muro ,&nbsp;Nobutaka Yamamoto ,&nbsp;Takaomi Taira","doi":"10.1016/j.inat.2025.101995","DOIUrl":null,"url":null,"abstract":"<div><div>Intrathecal baclofen therapy (ITB) is a well-established treatment for limb spasticity due to brain and spinal cord disorders, and it is also indicated for dystonia, though mainly reported in generalized or pediatric cases. This report highlights a 46-year-old male with hemidystonia from writer’s cramp. Diagnosed at age 30, his symptoms persisted despite oral medications, botulinum toxin injections, and deep brain stimulation targeting the left thalamus ventro-oral nucleus and globus pallidus internus. Two years later, his symptoms worsened and extended to the right side. At our clinic, a baclofen screening test significantly reduced muscle tone, enabling writing. Following the implantation of a baclofen pump, his dystonia markedly improved, restoring his writing ability. This case supports considering ITB for patients with severe, refractory dystonia and muscle hypertonus, even in cases without generalized dystonia.</div></div>","PeriodicalId":38138,"journal":{"name":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management","volume":"39 ","pages":"Article 101995"},"PeriodicalIF":0.4000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214751925000076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Intrathecal baclofen therapy (ITB) is a well-established treatment for limb spasticity due to brain and spinal cord disorders, and it is also indicated for dystonia, though mainly reported in generalized or pediatric cases. This report highlights a 46-year-old male with hemidystonia from writer’s cramp. Diagnosed at age 30, his symptoms persisted despite oral medications, botulinum toxin injections, and deep brain stimulation targeting the left thalamus ventro-oral nucleus and globus pallidus internus. Two years later, his symptoms worsened and extended to the right side. At our clinic, a baclofen screening test significantly reduced muscle tone, enabling writing. Following the implantation of a baclofen pump, his dystonia markedly improved, restoring his writing ability. This case supports considering ITB for patients with severe, refractory dystonia and muscle hypertonus, even in cases without generalized dystonia.
鞘内输注巴氯芬改善半肌张力障碍1例
鞘内巴氯芬治疗(ITB)是一种公认的治疗脑和脊髓疾病引起的肢体痉挛的方法,它也适用于肌张力障碍,尽管主要报道在全身或儿科病例中。本报告报告了一位46岁男性,因作家痉挛而出现半肌痉挛。他在30岁时确诊,尽管口服药物,注射肉毒杆菌毒素,并针对左侧丘脑腹口核和内苍白球进行深部脑刺激,但症状仍然存在。两年后,他的症状恶化并延伸到右侧。在我们的诊所,巴氯芬筛选试验显著降低了肌肉张力,使书写成为可能。在植入巴氯芬泵后,他的肌张力障碍明显改善,恢复了他的写作能力。本病例支持对严重、难治性肌张力障碍和肌肉张力亢进患者考虑ITB,即使在没有全身性肌张力障碍的病例中也是如此。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
236
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信